Trials / Unknown
UnknownNCT04787588
COVID-19 Infection and Epithelial Cell Markers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 235 (estimated)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To assess if TSLP expression by airway epithelial cells following COVID-19 infection regulates viral load and disease severity.
Detailed description
The study aim is to determine the relationship between COVID-19 infection and epithelial cell expression of TSLP. Two cohorts will be used. Cohort One will include 100 hospitalized patients with Covid-19, and 100 hospitalized patients without Covid-19. Cohort 2 will include mild/moderate asthmatics and healthy controls with bio-banked biopsy material used from donors who have previously consented for samples to be used for future research.
Conditions
Timeline
- Start date
- 2021-02-14
- Primary completion
- 2021-12-01
- Completion
- 2022-02-01
- First posted
- 2021-03-08
- Last updated
- 2021-03-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04787588. Inclusion in this directory is not an endorsement.